PMID: 12181049Aug 16, 2002Paper

Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis

British Journal of Haematology
Massimo LibraMauro Boiocchi

Abstract

Relapses in non-Hodgkin's lymphomas (NHL) could be due to the reappearance of the initial neoplasm or new primary tumours. Discrimination between the two events would allow a more targeted therapeutic approach. VDJ rearrangement was used as marker of clonality in metachronous biopsy specimens from 10 patients with relapsed B-NHL. Complimentary determining region 3 was amplified and sequenced. D-JH was identical in eight matched primary/secondary tumours, confirming the diagnosis of recurrence. In contrast, primary and secondary tumours in two patients were of different clonal origin. Our data indicate that VDJ analysis is a fundamental tool for identification of relapses in NHL.

References

Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J BiermanJ O Armitage
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Oct 3, 1999·Current Opinion in Oncology·P McLaughlin
Mar 14, 2000·The Korean Journal of Internal Medicine·D H LeeT H Lee

❮ Previous
Next ❯

Citations

Dec 31, 2008·Applied Immunohistochemistry & Molecular Morphology : AIMM·Shih-Sung ChuangLi-Ching Lin
Jun 21, 2019·Virchows Archiv : an International Journal of Pathology·Etan MarksYanhua Wang
Sep 17, 2004·Leukemia & Lymphoma·Massimo LibraMauro Boiocchi
Feb 6, 2016·Oncotarget·Seung Eun LeeYoung Hyeh Ko
Jun 15, 2013·American Journal of Clinical Pathology·Willemina R R Geurts-GieleAnton W Langerak

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.